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The phytochemical study of Hippeastrum goianum led to the identification of 13 compounds 
by means of gas chromatography-mass spectrometry (GC-MS) and nuclear magnetic resonance 
(NMR). Compounds 7-demethoxy-9-O-methylhostasine (1) and 7-deoxi-trans-dihydronarciclasine 
(2) had their absolute configurations determined by vibrational circular dichroism (VCD). This 
is the first time that compound 1 is described in the Amaryllidaceae family. The cytotoxicity of 
all isolated compounds was tested against colorectal carcinoma (HCT 116), breast carcinoma 
(MCF-7), and non-tumor human retinal pigment epithelium (RPE) cell lines. The half-maximum 
inhibitory concentration (IC50) of compound 2 against each cell line was equivalent to the positive 
control (doxorubicin), indicating a considerable cytotoxic activity.
Keywords: narciclasine, galasine, cytotoxic activity, absolute configuration, vibrational 
circular dichroism
Introduction
The genus Hippeastrum, belonging to the Amaryllidaceae 
family, Hippeastreae tribe, subfamily Amaryllidoideae, has 
about 70 species, distributed throughout Latin America, 
particularly in Brazil. The latest research pointed to the 
occurrence of about 30 Brazilian species, including 21 
that are considered endemic.1 Several studies2 showed a 
peculiar taxonomy of the genus Hippeastrum, reinforcing 
the significance of chemical and pharmacological studies 
with these plants. Bulbs from many species of the genus 
Hippeastrum yielded numerous alkaloids, with 64 being 
fully characterized.2 Considering the promising biological 
activities showed by these alkaloids, such as cytotoxic,3 
psychopharmacological4 and acetylcholinesterase (AChE) 
inhibitory activities,5 this class of compounds is of 
remarkable importance.
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Isoquinolinic alkaloids from Amaryllidaceae plants, 
especially the narciclasine-type derivatives, have 
pronounced cytotoxic activities6 and might be helpful in 
the cancer therapy. Cancer is a serious disease, considered 
the main cause of death in the world and many products 
used in the cancer therapy are natural products or natural 
products derivatives.7-9 Therefore, it is important to search 
for new compounds that can be used against cancer.
This study was focused on Hippeastrum goianum 
(Ravenna) Meerow, an endemic species of Brazil, growing 
in the central-west part of the country, precisely in the 
Cerrado ecosystem.10 Considering that little information on 
the phytochemical composition of H. goianum is available,11 
gas chromatography-mass spectrometry (GC-MS) based on 
qualitative and relative quantitative analysis was performed 
on hexane (n-Hex) and ethyl acetate (EtOAc) alkaloid-
enriched extracts of the bulbs from this species. Out of 
the thirteen compounds identified by GC-MS, five were 
isolated and evaluated for cytotoxic activity against colon 
adenocarcinoma (HCT-116), breast carcinoma (MCF-7), 
and non-tumor retinal pigment epithelium (RPE) cell lines. 
Compounds 7-demethoxy-9-O-methylhostasine (1) and 
7-deoxi-trans-dihydronarciclasine (2) had their absolute 
configurations determined by using vibrational circular 
dichroism (VCD) and compound 1 is reported for the first 
time in Amaryllidaceae family.
Experimental
General experimental procedures 
The column chromatographic separations (CC) were 
done using silica gel (70-90 µm, Agela Technologies, 
Phenomenex Company, China) or Sephadex® (LH-20, GE 
Healthcare, USA). All Sephadex® columns were performed 
using methanol pro analysis (P.A.) (MeOH, LabSynth, 
Brazil) as mobile phase. For the acid-base extraction, the 
solvents sulfuric acid, ammonium hydroxide, n-hexane, 
ethyl acetate (EtOAc), and dichloromethane (DCM) of 
analytical grade were used (LabSynth, Diadema, Brazil). 
Preparative thin layer chromatography (PTLC) was 
performed with pre-coated aluminum plates with silica gel 
F254 (Macherey-Nagel®, France). The plates were analyzed 
by exposure under ultraviolet (UV) light (254 and 366 nm) 
and spraying with Dragendorff reagent. High-performance 
liquid chromatography (HPLC) purifications were done 
on an Agilent Chromatograph, coupled with a diode 
array (DAD) detector (1260 MWD), using a semi-
preparative column (Eclipse XDB-18, 5 µm of particle 
size, 9.4 × 250 mm). All employed solvents were analytical 
grade, or HPLC grade when needed (LabSynth, Diadema, 
Brazil). Gas chromatography analyses were performed on 
a GC-17A Shimadzu GC-MS QP 5000 operating in the 
electronic impact (EI) mode at 70 eV using a DB5 MS 
column (30 m × 0.25 mm × 0.25 µm). The temperature 
program was as follows: 100-180 ºC at 15 ºC min-1, 1 min 
hold at 180 ºC and 180-300 ºC at 5 ºC min-1 and 10 min 
hold at 300 ºC. The injector temperature was 280 ºC. The 
flow rate of carrier gas (helium) was 0.8 mL min-1, and 
the split ratio was 1:20. The Amaryllidaceae alkaloids 
identified by GC-MS had their mass spectra deconvoluted 
using AMDIS 2.64 software (NIST)12 and retention indices 
(RIs) recorded using a standard n-hydrocarbon calibration 
mixture (C9-C36). Thus, their GC-MS spectra and Kovats 
RI were compared to those presented in our library 
database. This library has been regularly updated with 
alkaloids isolated and unequivocally identified via physical 
and spectroscopic methods.
The 1H, 13C and two-dimensional (2D) nuclear magnetic 
resonance (NMR) spectra were performed in a VNMRS400 
spectrometer, operating at 9.4 T, using a 5 µm 1H/X/D 
BroadBand probe. Deuterated chloroform (CDCl3), 
methanol (CD3OD) and dimethyl sulfoxide (DMSO-d6) 
were used as solvent (Sigma-Aldrich, Steinheim, 
Germany). The nuclear Overhauser enhancement difference 
(NOEdiff) experiments were performed applying the 
one-dimensional nuclear Overhauser effect spectroscopy 
(1D-NOESY) pulse sequence, with the mixing time 
optimization for each experiment. HRESIMS (high-
resolution electrospray ionization mass spectrometry) 
was performed on 9.4 T FT-ICRMS (Solarix, Germany) 
by direct injection of the compound dissolved in MeOH. 
Infrared (IR) and VCD spectra of 1 and 2, were recorded 
with a Single-PEM Chiral IR-2X FT-VCD spectrometer 
(BioTools, Inc, Jupiter, FL, USA) using a resolution 
of 4 cm−1 and a collection time of 7 h. The optimum 
retardation of the ZnSe photoelastic modulator (PEM) was 
set at 1400 cm−1. Minor instrumental baseline offsets were 
eliminated from the final VCD spectrum by subtracting the 
VCD spectrum of each compound from that obtained for 
the solvent under identical conditions. The IR and VCD 
spectra were recorded in a BaF2 cell with 100 µm path length 
using DMSO-d6 as solvent. The samples were prepared as 
follows: 6 mg of compound 1 and 3 mg of compound 2, 
both dissolved in 120 µL of DMSO-d6.
Plant material 
Bulbs from Hippeastrum goianum (Ravenna) Meerow 
were harvested at the University of Brasília, Brasília, 
Distrito Federal, Brazil in September 2016. The material 
was identified by Dr Sarah Christina Caldas Oliveira and 
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a voucher was deposited at the Herbarium of the Federal 
University of Espírito Santo (VIES 39499). Registration 
SisGen No. A012E5E.
Extraction and isolation 
Bulbs (2.1 kg) were dried at 40 ºC and crushed. The 
resulting material (579 g) was extracted with MeOH 
(4 times, 24 h each). The dried extract (148 g) was acidified 
with sulfuric acid (2%) to pH 2 and further extracted with 
petroleum ether (PE) (3 × 200 mL) and ethyl acetate 
(EtOAc) (3 × 200 mL). The aqueous solution was basified 
with ammonium hydroxide (30%) to pH 9-10 and then 
extracted with n-hexane (7 × 150 mL) to give extract C 
(57.3 mg), EtOAc (20 × 150 mL) to produce extract D 
(8.2 g), from which compound 2 precipitated (530.6 mg), 
and EtOAc-MeOH (3:1) (3 × 150 mL) that gave extract E 
(9.2 g), all of which showed positive results for alkaloids 
according to Dragendorff’s reagent. Extracts C and D 
were analyzed by GC-MS. Extract D was fractionated 
by Sephadex® column eluted with MeOH, resulting in 
69 fractions, grouped in three main fractions. Fraction D.2 
(6.6 g) was subjected to Sephadex® column giving 
50 fractions, combined in four subfractions based on TLC 
profiles. Subfraction D.2.2 (732.3 mg) was submitted to a 
new Sephadex® column resulting in 81 fractions, grouped 
in five subfractions. Subfraction D.2.2.2 (517.9 mg) was 
fractionated by silica gel CC eluted on EtOAc containing 
increasing amounts of a solution with DCM and MeOH 
(1:1) until the proportion of the mixture DCM-MeOH 
reached 100%. This resulted in 111 fractions that were 
grouped in five subfractions after TLC analysis. Subfraction 
D.2.2.2.2 (60.6 mg) was identified as compound 1. Fraction 
D.2.3 (5.7 g) was submitted to silica gel CC first eluted with 
EtOAc, then gradients of DCM-MeOH (1:1, 0 → 100%) 
were added, yielding 262 fractions and combined in 
11 subfractions. Subfractions D.2.3.4, D.2.3.7, D.2.3.8 
and D.2.3.10 showed positive results for alkaloids (positive 
Dragendorff’s spots). Subfraction D.2.3.4 (578.8 mg) was 
subjected to silica gel CC eluted with EtOAc followed 
by gradients of DCM-MeOH (1:1, 0 → 100%) providing 
112 fractions, which were combined in four subfractions. 
Compound 1 was obtained from subfraction D.2.3.4.2 
(321.0 mg) after PTLC in n-hexane-DCM-EtOAc-acetone-
MeOH (3:1.5:2:1.5-5 drops of ammonium hydroxide were 
add into the solvent system) as elution system. Subfraction 
D.2.3.7 (254.8 mg) was submitted to Sephadex® column, 
resulting in 60 fractions grouped in nine subfractions. 
Subfraction D.2.3.7.5 (41.1 mg) was subjected to PTLC 
in EtOAc-CHCl3-acetone-MeOH (5:5:3:5), resulting in 
the precipitation of compound 11 (9.4 mg). Subfraction 
D.2.3.8 (588.2 mg) was submitted to Sephadex® column, 
resulting in 62 fractions grouped in five subfractions. 
Compound 13 (4.3 mg) precipitated from subfraction 
D.2.3.8.2 (206.7 mg). Subfraction D.2.3.10 (267.4 mg) was 
subjected to Sephadex® column resulting in 60 fractions 
combined in four subfractions. Subfraction D.2.3.10.1 
(175.9 mg) was fractionated with CC of silica gel eluted 
with DCM, gradients of MeOH on DCM and pure MeOH, 
yielding 74 fractions, grouped in four subfractions. 
Subfraction D.2.3.10.1.2 (16.3 mg) was submitted to 
HPLC fractionation employing a gradient method with 
H2O and MeOH. The method (7 mL min-1) increased the 
amount of MeOH from 10 to 50% in 20 min, then returned 
to 10% in 5 min, and this percentage was kept for 10 min. 
The first band that eluted at 3.14 min was extracted with 
CHCl3-MeOH (4:1) and identified as compound 6 (2.0 mg).
Cell culture and MTT assay
HCT-116 (colon adenorcarcinoma) cells were grown 
in Roswell Park Memorial Institute medium (RPMI) and 
MCF-7 (breast carcinoma) and RPE (non-tumor retinal 
pigment epithelium) cells were grown in Dulbecco’s 
modified Eagle medium (DMEM). Both media were 
supplemented with 10% fetal bovine serum (FBS) and 1% 
antibiotics (penicillin 10,000 Units mL-1 and streptomycin 
10,000 µg mL-1). Cells were kept in an incubator with 
5% CO2 at 37 °C. For 3-[4,5-dimethylthiazole-2-yl]-
2,5-diphenyltetrazolium bromide (MTT) assay, the cells 
were seeded on 96-well plates at a density of 1 × 104 per 
well with 200 µL culture medium. After 24 h, compounds 
1, 2, 6, 11 and 13 (0.0032-50 µM) were added to the 
cultures and incubated for 72 h. DMSO (0.05%) was 
used as negative control and the antineoplastic compound 
doxorubicin (0.00064-10 µM) was used as positive control. 
Three hours before the end of the experiment, culture 
media were replaced by fresh media containing MTT 
solution (0.5 mg mL-1) and incubated. The MTT solution 
was removed and the formazan product was solubilized in 
150 µL DMSO. The absorbance was obtained at 540 nm. 
The IC50 values and their 95% confidence interval were 
calculated by sigmoidal nonlinear regression using 
GraphPad Prism 8.0 software.13
Calculations
Conformational searches were carried out at the 
molecular mechanics level of theory with the Monte Carlo 
algorithm employing the MM+ force field incorporated in 
HyperChem 8.0.10 software package.14 Calculations were 
performed for the arbitrarily chosen (1R,2S,4aR,10bR)-1 
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and (2S,3R,4S,4aR,10bR)-2. Initially, 68 conformers of 
(1R,2S,4aR,10bR)-1 with relative energy (rel E.) within 
10 kcal mol−1 of the lowest-energy conformer were 
selected and further geometry optimized at the B3LYP/
PCM(DMSO)/6-31G(d) level. The five conformers with 
rel E. < 1.0 kcal mol−1 were selected for IR and VCD 
spectral calculations. The inclusion of explicit DMSO 
molecules was performed using Hyperchem software,14 
on the optimized conformers of compound 1 obtained 
at the B3LYP/PCM(DMSO)/6-31G(d) level, which 
were subsequently subjected to geometry optimization 
and frequency calculations at the same level. As for 
(2S,3R,4S,4aR,10bR)-2, 12 conformers with relative energy 
(rel E.) within 10 kcal mol−1 of the lowest-energy conformer 
were selected and further geometry optimized at the 
B3LYP/PCM(DMSO)/6-31G(d) level. The four conformers 
with rel E. < 1.2 kcal mol−1 were selected for IR and VCD 
spectral calculations. All density functional theory (DFT) 
calculations were carried out at 298 K in DMSO solution 
using the polarizable continuum model (PCM) in its integral 
equation formalism version (IEFPCM) incorporated in 
Gaussian 09 software.15 For the IR and VCD spectral 
simulations, the spectra were created using dipole and 
rotational strengths from Gaussian, which were calculated 
at the same level used during the geometry optimization 
step, and converted into molar absorptivities (M−1 cm−1). 
Each spectrum was plotted as a sum of Lorentzian bands 
with half-widths at half-maximum of 6 cm−1. The calculated 
wavenumbers were multiplied with a scaling factor of 
0.975. The final spectra were generated according to 
Boltzmann weighting of the lowest-energy conformers 
identified and plotted using Origin 8 software.16
7-Demethoxy-9-O-methylhostasine (1)
Amorphous yellowish solid. 1H and 13C NMR data see 
Table 1 and Figures S1-S10 (Supplementary Information 
(SI) section). HRESIMS m/z, calcd. for C18H22NO6+ 
[M + H]+: 348.14417, found: 348.14458; calcd. for 
C36H43N2O12+ [2M + H]+: 695.28105, found: 695.28416; 
calcd. for C54H63N3NaO18+ [3M + Na]+: 1064.39989, 
found: 1064.40808; calcd. for C72H84N4NaO24+ [4M + Na]+: 
1411.53677, found: 1411.55830 (Figure S11, SI section).
7-Deoxi-trans-dihydronarciclasine (2)
Amorphous white solid. 1H and 13C NMR data see 
Table 2 and Figures S13-S19 (SI section). HRESIMS 
m/z, calcd. for C14H16NO6+ [M + H]+: 294.09722, found: 
294.09717; calcd. for C28H31N2O12+ [2M + H]+: 587.18715, 
Table 1. NMR data for compound 1 in 400 MHz and comparison with the literature (400 MHz, MeOD)17
Position dH, mult. (J / Hz)a dCa,b COSYa HMBCa dH, mult. (J / Hz)c dCc HMBCc dH, mult. (J / Hz)17 dC17
1 3.82 brs 76.3 N.O. 10b 3.60 brt (1.2) 78.1 N.O. 3.60 s 78.1
2 4.13 brs 70.9 3 N.O. 4.09-4.13 m 72.4 N.O. 4.10 s 72.4
3 5.70 brs 118.2 2, 4a, 11 N.O. 5.67-5.71 m 120.2 N.O. 5.70 brs 120.3
4 - 141.7 - - - 141.7 - 141.6
4a 3.40 brs 65.5 3, 11 N.O. 3.47-3.50 m 67.1 4, NMe 3.49 s 67.1
6 - N.O. - - - 171.5 - 171.4
6a - 117.4 - - - 118.7 - 118.8
7 7.28 s 106.0 N.O. 9, 10a 7.36 s 107.5 6, 9, 10a 7.34 s 107.0
8 - 150.9 - - - 152.7 - 152.7
9 - 154.4 - - - 156.3 - 156.3
10 7.23 s 105.5 N.O. 6a, 8, 9 7.35 s 107.1 6a, 8 7.35 s 107.5
10a - 145.6 - - - 147.2 - 147.1
10b - 83.7 - - - 85.1 - 85.0
11α/β 2.47-2.55 m 27.7 3, 12α, 12β 4 2.41-2.62 m 28.8 N.O. 2.58 m-2.48 m 28.7
12α 3.10 ddd (9.6, 6.0, 4.0) 55.2 11, 12β N.O. 3.04 ddd (9.6, 8.0, 2.4) 56.7 4 3.05 m 56.8
12β 2.27 q (9.6) 11, 12α N.O. 2.33 q (9.6) NMe 2.36 dd (18.4, 9.2)
8-OCH3 3.92 s 56.1 - 8 3.92 s 56.7 8 3.92 s 56.7
9-OCH3 3.97 s 56.3 - 9 3.97 s 56.9 9 3.96 s 56.9
N-CH3 1.61 s 43.2 - 4a, 12 1.65 s 43.4 4a, 12 1.66 s 43.4
aCDCl3; bshifts were obtained using the correlations observed in the HSQC and HMBC spectra; cMeOD. dH: chemical shift of hydrogen; mult.: multiplicity 
of hydrogen; J: coupling constants; dC: chemical shift of carbon-13; HMBC: heteronuclear multiple bond correlation; N.O.: not observed.
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found: 587.18702; calcd. for C28H30N2NaO12+ [2M + Na]+: 
609.16910, found: 609.16907 (Figure S20, SI section).
Results and Discussion
GC-MS analyses
The alkaloids identified from the bulbs of H. goianum 
through GC-MS analysis are shown in Table 3 and Figure 1. 
It is not common to observe a high content of primary 
metabolites in an alkaloid-enriched extract obtained 
by acid-base extraction, however, the n-hexane extract 
was composed of approximately 70% of hexadecanoic, 
octadecenoic and octadecadienoic acid derivatives. It 
is well-documented that the GC-MS method applied 
herein for Amaryllidoideae plant matrices detects 
primary metabolites in short retention time (data not 
shown).20 Regarding the Amaryllidaceae alkaloids 
detected by GC-MS, galanthamine, crinane, lycorine 
and homolycorine-type series have been determined in 
bulbs of the species (Table 3). The hostasine derivative 
7-demethoxy-9-O-methylhostasine (1) was the main 
component in the EtOAc fraction (43.7%) followed by 
9-O-demethyllycoramine (6-20.9%), lycorine (11-14.7%) 
and pseudolycorine (13-8.0%). The outstanding structural 
difference between a galasine-type and a homolycorine-
type derivative is the presence of a five-member lactone in 
the former rather than a six-membered one in the latter,21 
even though the pyrrolidine moieties in both skeleton 
series are essentially the same. Actually, it has been noticed 
parallels between the electronic impact-mass fragmentation 
of 1 and that observed for the typical homolycorine-type 
skeleton.22 The low abundance of the molecular ion and 
the base peak at m/z 125 in 1 were also detected in the 
electronic impact-mass fragmentation of the 2-hydroxy 
substituted homolycorine-type derivative hippeastrine.23 
The fragmentation route of homolycorine-type alkaloids 
under electronic impact (EI) ionization method is well 
established and is dominated by the retro-Diels-Alder 
reaction in the hexahydroindole ring, which leads to the 
cleavage of the labile bonds and generates a base peak 
fragment representative of the pyrrolidine ring moiety 
(m/z 109), along with any substituent at C-2.21-23 Thus, as 
in 2-hydroxyhomolycorine-type derivatives, the m/z 125 
Table 2. NMR data for compound 2 (400 MHz, DMSO-d6) and comparison with literature18,19
Position dH, mult. (J / Hz) dC COSY HMBC
dH, mult. 
(J / Hz)19 
(300 MHz, DMSO-d6)
dH18 (500 MHz, 
DMSO-d6)
dC18 (125 MHz, 
DMSO-d6)
1α 2.14 dt (13.2, 3.4) 28.4 1β, 2, 3, 10, 10b 2, 3 1.59 dt (13.4, 2.3) 2.14 dt 28.2
1β 1.64 td (13.2, 2.4) 1α, 2, 10b 10b 2.12 brd (13.3) 1.65 td
2 3.89 s 68.7 1α, 1β, 3, 2-OH 4, 10b 3.84 s 3.70 s 69.6
3 3.72 brs 71.7 1α, 2, 3-OH, 4 1, 4a 3.68 brs 3.87 s 68.5
4 3.72 brs 69.8 3, 4a, 4-OH 4a 3.68 brs 3.70 s 71.6
4a 3.31 dd (12.4, 9.6) 55.2 4, 10b 4 3.23 m 3.31 s 55.0
6 - 164.4 - - - - 164.2
6a - 123.3 - - - - 123.2
7 7.30 s 107.0 10 6, 9, 10a 7.30 s 7.29 s 106.8
8 - 146.0 - - - - 145.8
9 - 150.7 - - - - 150.5
10 6.92 s 104.4 1α, 7, 10b 7, 8, 9, 10b 6.89 s 6.92 s 104.2
10a - 138.1 - - - - 137.9
10b 2.88 td (12.4, 3.6) 34.3 1α, 1β, 4a, 10 4a, 10a 2.84 dt (12.8, 3.4) 2.90 td 34.2
2-OH 5.02 s - 2 - 4.91 s 4.96 s -
3-OH 4.84 s - 3 - 4.74 s 4.92 s -
4-OH 4.96 s - 4 - 4.91 s 4.80 s -
5-NH 6.93 s - - 4, 4a, 6, 6a 6.89 s 6.92 s -
OCH2O 6.06 s 101.7 - 8, 9 6.03 s 6.06 s 101.5
dH: chemical shift of hydrogen; mult.: multiplicity of hydrogen; J: coupling constants; dC: chemical shift of carbon-13; COSY: homonuclear correlation 
spectroscopy; HMBC: heteronuclear multiple bond correlation.
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in 1 is consistent with the pyrrolidine ring moiety along 
with the hydroxyl substituent at C-2. Further evaluations 
under EI ionization source of galasine-type compounds are 
needed to confirm their fragmentation mode in EI mass 
spectrometry. The galasine-type skeleton was found for the 
first time in Galanthus genus in 1995,24 and only recently 
was characterized in the species Hosta plantaginea, a 
representative of the Asparagaceae family.
The alkaloids 8-O-demethylhomolycorine (12) and 
sanguinine (4) were also detected as minor components 
in addition to some undefined compounds, which were 
determined as homolycorine representatives due to the base 
peaks both at m/z 125 and 109. Regarding the n-hexane 
extract, similarly to what was mentioned above, the alkaloid 
relative content observed by GC-MS was remarkably 
smaller than the percentage of primary metabolites. In this 
fraction, the two main compounds detected by GC-MS were 
undefined alkaloids corresponding to 11.3 and 8.3% of the 
TIC. These two compounds along with the other undefined 
alkaloids (2.0%) have demonstrated electronic impact-
mass fragmentation typical to Amaryllidaceae alkaloids, 
even though the use of fragmentation patterns based solely 
on EI-MS technique is not enough for any speculation 
about the skeleton-type. The small relative percentage of 
these undefined compounds and the low mass of extract 
in n-hexane (57.3 mg) were evident limitations for their 
purification and characterization. Lycorine derivatives, such 
as anhydrolycorine (8-2.5%) and dihydro-1-acetyllycorine 
(10-0.9%), along with the aulicine (9-2.1%) showed low 
relative percentage and galanthamine (3) along with vittatine/
crinine (7/7a) were detected as traces (less than 0.5%).
NMR approaches
In the course of the fractionation procedure, the hostasine 
derivative 7-demethoxy-9-O-methylhostasine (1), the 
narciclasine derivative 7-deoxi-trans-dihydronarciclasine (2), 
9-O-demethyllycoramine (6), lycorine (11) and 
pseudolycorine (13) were purified from the bulbs of 
H. goianum. Additionally, seven compounds were identified 
by means of GC-MS approaches. The chemical structures 
of the 13 identified compounds are shown in Figure 2.
Compound 1 was isolated as an amorphous yellowish 
solid with molecular formula determined by HRESIMS 
data, displaying a m/z 348.14458 peak consistent 
with the [M + H]+ ion for the molecular formula 
C18H22NO6, with theoretical m/z 348.14417. It is consistent 
with nine indices of hydrogen deficiency. The NMR 
data for compound 1 were very similar to those of 
8-demethoxy-10-O-methylhostasine,17 which is also named 
as 7-demethoxy-9-O-methylhostasine, according to the 
numbering proposed by Ghosal et al.25 The downfield 
region of the 1H NMR of compound 1 showed two para aryl 
hydrogens at dH 7.36 (s, H-7) and at dH 7.35 (s, H-10) along 
with an olefinic hydrogen at dH 5.67-5.71 (m, H-3) and two 
resonances at dH 3.60 (brt, 1.2 Hz, H-1) and at dH 4.09-4.13 
(m, H-2), which were consistent with the oxymethinic 
hydrogens H-1 and H-2, respectively. The two aromatic 
methoxyl groups were suggested by the chemical shift 
at dH 3.92 (s) and at dH 3.97 (s) (3H both) and confirmed 
through HMBC experiment as 8-OMe and 9-OMe groups 
(Table 1), respectively. The N-methyl group was assigned 
as a singlet at dH 1.65, in agreement to its homologous in 
8-demethoxy-10-O-methylhostasine.17 Striking differences 
were observed in the splitting pattern of the methylene 
positions of the pyrrolidine ring, in comparison to the 
NMR data of 8-demethoxy-10-O-methylhostasine.17 
As observed in others homolycorine derivatives, the 
H-12α was split into a ddd with the geminal coupling 
constant J12α,12β = 9.6 Hz, which is in agreement with other 
homolycorine-and lycorine-type series, the latter of which is 
biogenetically related to homolycorines.26,27 In this attempt, 
Figure 1. GC-MS spectra of the fractions (a) n-hexane and (b) ethyl acetate, obtained from bulbs of Hippeastrum goianum.
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the complete and correct assignment for compound 1 is 
suggested at Table 1 and confirmed it as 7-demethoxy-
9-O-methylhostasine. This is the first time that a hostasine 
derivative is isolated from a species of Amaryllidaceae. Based 
on the relative configuration determined from NMR data, the 
absolute configuration of compound 1 was unambiguously 
assigned by comparison of experimental and calculated VCD 
spectra. The correlation between observed and theoretical 
data obtained at the B3LYP/PCM(DMSO)/6-31G(d) level 
(Figure S12, SI section) led to the assignment of compound 1 
as 1R,2S,4aR,10bR. It is noteworthy that the best agreement 
with experimental data was observed after the inclusion 
of explicit DMSO solvation during the DFT simulation.28 
This compound was previously isolated only from 
Hosta plantaginea a species from the family Asparagaceae.17 
This is the first report of 7-demethoxy-9-O-methylhostasine 
in the Amaryllidoideae subfamily. 
Compound 2 had its molecular formula determined by 
the HRESIMS signal of m/z 294.09717, consistent with the 
[M + H]+ ion for the molecular formula C14H16NO6, with 
theoretical m/z 294.09722. Its 1H NMR spectrum showed 
signals due to aromatic hydrogens at dH 7.30 (s, H-7) and 
dH 6.92 (s, H-10), a NH hydrogen at dH 6.93 (s, NH-5), 
three hydroxyl groups at dH 5.02 (s, 2-OH); at dH 4.96 (s, 
4-OH) and at dH 4.84 (s, 3-OH); and two hydrogens with 
a trans relationship at dH 2.88 (td, 12.4, 3.6 Hz, H-10b) 




n-Hex / % EtOAc / %
Galanthamine (3) 2394 tr - 287(83) 286(100), 270(13), 244(24), 230(12), 216(33), 
174(27), 115(12)
Sanguinine (4) 2403 - 1.0 273(100) 272(79), 256(18), 216(18), 202(37), 160(44), 
115(25)
Lycoramine (5) 2410 2.6 - 289(62) 288(100), 232(8), 202(14), 187(14), 159(9), 
115(19)
9-O-Demethyllycoramine (6) 2463 - 20.9 275(55) 274(100), 174(10), 173(14), 145(10), 131(11), 
115(14), 44(35)
Vitatine (7), crinine (7a)a 2470 tr - 271(100) 228(25), 199(95), 187(85), 173(28), 128(32), 
115(33), 56(22)
Anhydrolycorine (8) 2501 2.5 - 251(43) 250(100), 192(13), 191(11), 165(4), 164(3), 
139(2), 124(7)
Aulicine (9) 2656 2.1 - 319(100) 304(19), 288(37), 246(18), 233(73), 218(19), 
206(26), 163(7)
Dihydro-1-acetyllycorine (10) 2737 0.9 - 331(41) 330(100), 270(28), 254(30), 226(10), 147(12), 
119(7), 89(5)
Lycorine (11) 2746 - 14.7 287(31) 286(19), 268(24), 250(15), 227(79), 226(100), 
211(7), 147(15)
Undefined A 2810 8.3 - 349(27) 318(19), 276(27), 248(100), 167(9), 142(17), 
96(25), 55(9)
8-O-Demethylhomolycorine (12) 2833 - 1.7 301(< 1) 195(0.5), 164(2), 109(100), 108(25), 94(3), 
82(3)
Undefined B (homolycorine-type 2-hydroxy 
substituted derivative)
2887 - 2.4 nd 181(14), 138(19), 125(100), 124(9), 111(5), 
96(57), 95(8)
Undefined C (homolycorine-type derivative) 2888 - 1.1 nd 194(5), 163(3), 109(100), 108(18), 92(3), 
66(4), 58(4)
Pseudolycorine (13) 2823 - 8.0 289(28) 270(19), 252(15), 228(100), 214(9), 147(16), 
111(18), 82(11)
Undefined D 2948 11.3 - 373(47) 372(100), 314(53), 272(45), 254(87), 212(14), 
147(26), 119(11)
Undefined E 2985 2.0 - 331(40) 330(100), 270(71), 254(22), 212(18), 147(36), 
91(23), 77(15)
7-Demethoxy-9-O-methylhostasine (1) 3057 - 43.7 nd 125(100), 124(8), 96(35), 81(3), 77(2), 67(2), 
53(3)
aThe known compounds 7 and 7a21 cannot be defined only by means of GC-MS. Compound 2 cannot be analyzed by GC-MS technique. RI: Kovats 
retention indices; M+: molecular ion; MS: MS fragments of the compounds by electron impact; nd: not detected; tr: traces. 
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and at dH 3.31 (dd, 12.4, 9.6 Hz, H-4a), which indicates 
a 1,10b-dihydronarciclasine derivative. According to the 
13C NMR spectrum, there are fourteen carbons, being one 
of them assigned to an acyl group at dC 164.4, six aromatic 
carbons (dC 104.4, 107.0, 123.3, 138.1, 146.0, 150.7), one 
methylenedioxide carbon (dC 101.7), five methine carbons 
(dC 34.3, 55.2, 68.7, 69.8, 71.7) and one methylene carbon 
(dC 28.4). Analysis of the COSY spectrum showed that 
H-10b has correlation with H-1β resonant at dH 1.64, H-1α 
(dH 2.14), H-4a (dH 3.31), and H-10 resonant at dH 6.92, while 
H-2 at dH 3.89 displayed correlation with H-1β (dH 1.64), 
H-1α (dH 2.14), H-3 (dH 3.72) and 2-OH (dH 5.02). These 
data were consistent with the structure of 7-deoxi-trans-
dihydronarciclasine (Figure 2, Table 3). COSY, NOE 
experiments and J values, allowed us to describe the relative 
stereochemistry of the stereogenic carbons. Irradiation of 
H-1β (dH 1.64) resulted in NOE with H-1α (dH 2.14), H-4a 
(dH 3.31), H-2 (dH 3.89), and H-10 (dH 6.92). When H-1α 
(dH 2.14) was irradiated, NOE was observed with H-1β 
(dH 1.64), H-10b (dH 2.88), H-2 (dH 3.89), and H-10 (dH 6.92). 
Additionally, H-10b (dH 2.88) was irradiated showing NOE 
with H-1α (dH 2.14), H-4 (dH 3.72), and H-10 (dH 6.92). The 
proposed relative stereochemistry is in accordance with 
the literature18 where H-1β has spatial interaction with its 
geminal hydrogen H-1α, as well as H-4a and H-2. The 
hydrogen H-2 is in gauche conformation between H-1α and 
H-1β and its spatial correlation would be observed for both 
irradiations on H-1. The relative configurations of H-2 and 
H-4 are corroborated by NOE experiments since only the 
irradiation on H-10b (dH 2.88) resulted in correlation with 
the oxymethinic hydrogen H-4. The 1D (one-dimension)-
NOE correlation of the irradiated H-1β, H-1α, and H-10b 
is depicted in Figure 3. 
The mono- and bi-dimensional NMR experiments 
(1D/2D NMR) were essential for the assignment of the 
relative configuration of 2, even though the overlapped 
H-3 and H-4 resonances along with the absence of 
resolved NOE correlation in the case of H-3 did not 
assure the orientation of the 3-hydroxyl group. To confirm 
the absolute stereochemistry of 2, VCD analyses were 
performed. The comparison of experimental and calculated 
IR and VCD data at the B3LYP/PCM(DMSO)/6-31G(d) 
led to the assignment of its absolute configuration as 
2S,3R,4S,4aR,10bR (Figure S21, SI section). In this case, 
simulations of implicit solvation using the polarizable 
continuum model (PCM) were enough for an accurate 
reproduction of the experimental spectra. This compound 
was first isolated from species of Hymenocallis genus19 and 
more recently from Scadoxus pseudocaulus, besides other 
species from the Amaryllidaceae family.29
Figure 2. Chemical structures of the isolated and identified compounds in Hippeastrum goianum.
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Compound 6 was identified as 9-O-demethyllycoramine 
after comparison of its NMR data (Figures S22-S25, SI 
section) with the literature. This compound was previously 
obtained from Lycoris radiata (Amaryllidaceae)30 and 
compounds 11 and 13 were identified as lycorine and 
pseudolycorine, respectively. These compounds are 
commonly found in Amaryllidaceae species.21 Their NMR 
data can be seen in Table S1 (SI section). 
Cytotoxic activity
Results of tumor growth inhibition obtained from MTT 
assay31 showed the sensitivity of colorectal (HCT-116) and 
breast (MCF-7) carcinoma cell lines, as well as of non-tumor 
retinal pigment epithelium cell line, for 7-deoxi-trans-
dihydronarciclasine (2) and pseudolicorine (13) (Table 4, 
Figure S28, SI section). The half-maximum inhibitory 
concentration (IC50) of narciclasine derivative (2) for each 
cell line is comparable to the positive control (doxorubicin), 
indicating its considerable cytotoxic activity. Compound 13 
is less cytotoxic than compound 2; however, it is ten times 
more selective to HCT-116 cell line in comparison to the 
non-tumor cell line RPE (Table 4). The high cytotoxicity 
of compound 2 from Hippeastrum goianum with IC50 
varying from 0.15 to 0.2 µM is consistent with the cytotoxic 
potential of Amaryllidaceae isocarbostyrils in general, 
which generally show IC50 smaller than 1 µM against 
carcinomas, gliomas and menanomas cells.32 Compound 2, 
isolated from Hymenocallis littoralis, showed potent 
cytotoxicity in a panel of cancer cell lines from different 
origins, including MCF-7, where they found a IC50 (0.1 µM) 
similar to the one obtained herein.33 Compound 2 is actually 
consistently less active than narciclasine, that presented IC50 
values ranging from 0.01 to 0.09 µM against four different 
cell lines.34 Pseudolycorine (13), isolated from another 
genus from the Amaryllidaceae family (Narcissus tazetta), 
Table 4. Mean inhibitory concentration (IC50) and confidence interval (95%) of the compounds 1, 2, 6, 11, 13 and the positive control doxorubicin in 












1  > 50 -  > 50 -  > 50 -
2 0.15 0.10-0.22 0.2 0.1-0.3 0.3 0.2-0.6
6  > 50 -  > 50 -  > 50 -
11  > 50 -  > 50 -  > 50 -
13 4.6 3.4-6.0 10.6 8.9-12.6 42.6 32.0-56.7
Doxorubicin 0.4 0.24-0.62 0.6 0.4-0.8 1.2 0.8-1.6
Figure 3. 1D-NOE correlation for compound 2.
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has previously shown promising cytotoxicity against two 
different cervical carcinoma cell lines.35 When isolated 
from H. solandriflorum,34 compound 13 showed higher 
cytotoxicity than observed herein, where the obtained IC50 
values against the tumor cell line HCT-116 were 5.4 times 
higher when compared to the previous work (IC50 0.85 µM).
Conclusions
In summary, thirteen Amaryllidaceae alkaloids were 
unambiguously identified from the indigenous Brazilian 
species Hippeastrum goianum by means of GC-MS, 
1D/2D-NMR, and VCD methods. For the first time in 
Amaryllidoideae species (former Amaryllidaceae family) 
compound 1 has been characterized. Compound 1 is a 
representative of a very uncommon five-membered lactone 
moiety skeleton in Amaryllidoideae plants, which has been 
very recently accepted as a new subgroup named galasine-
skeleton. The determination of another representative of 
the galasine-type skeleton in Amaryllidoideae subfamily 
is an outstanding finding in terms of chemotaxonomy. 
Furthermore, the complete and unambiguous NMR 
data for compound 1 along with the determination of 
its absolute configuration by means of VCD is reported 
herein. Compound 2 is a representative of the cytotoxic 
skeleton narciclasine-type, an isocarbostyril derivative. 
The complete and unambiguous assignment of 2 using 
1D/2D NMR experiments led to the relative configuration 
of its stereocenters. The use of VCD spectroscopy allowed 
the determination of its absolute configuration, confirming 
the typical stereochemistry described in narciclasine-
type skeletons from Amaryllidoideae plants. VCD has 
been successfully applied for stereochemical studies 
of a tazettine derivative,36 but this is the first time VCD 
spectroscopy is used in narciclasine-type alkaloids. In terms 
of the cytotoxic activity of 2, it has been previous studied 
against a wide range cancer cell lines, and the observed IC50 
values are in the same range (0.1-0.2 µM) than the ones 
described herein, endorsing 2 as a promising anticancer 
compound. These findings emphasize the great chemical 
and biological potential of the Amaryllidoideae species.
Supplementary Information
Supplementary information (NMR, VCD and MS 
data) are available free of charge at http://jbcs.sbq.org.br 
as PDF file.
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